Bal Pharma Limited (BOM:524824)
88.84
+1.23 (1.40%)
At close: Jun 18, 2026
Bal Pharma Revenue
In the fiscal year ending March 31, 2026, Bal Pharma had annual revenue of 3.12B INR with 2.83% growth. Bal Pharma had revenue of 840.76M in the quarter ending March 31, 2026, with 2.69% growth.
Revenue
3.12B
Revenue Growth
+2.83%
P/S Ratio
0.45
Revenue / Employee
3.16M
Employees
986
Market Cap
1.41B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 3.12B | 85.78M | 2.83% |
| Mar 31, 2025 | 3.03B | -361.36M | -10.65% |
| Mar 31, 2024 | 3.39B | 350.03M | 11.51% |
| Mar 31, 2023 | 3.04B | 230.02M | 8.18% |
| Mar 31, 2022 | 2.81B | 306.86M | 12.25% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Bilcare | 7.34B |
| Parnax Lab | 2.49B |
| Lactose (India) | 1.63B |
| Aayush Wellness | 1.55B |
| Oxygenta Pharmaceutical | 1.13B |
| Accretion Pharmaceuticals | 898.18M |
| Coral Laboratories | 859.00M |
| Speciality Medicines | 761.14M |